Gatske Nieuwenhuyzen-de Boer (G M Nieuwenhuyzen-de Boer, Gatske M Nieuwenhuyzen-de Boer)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 19

Top Topics

Systematic Review

Patients Undergoing

Metastatic Renal Cell Carcinoma

Ejection Fraction

Top Venues

Journal of ovarian research

This page only lists publications with an associated author ORCID identifier.

Publications

Tugce Senturk Kirmizitas, Caroline van den Berg, Ruben G Boers, Jean Helmijr, Stavros Makrodimitris, Hamit Harun Dag, Marijn Kerkhofs, Corine Beaufort, Jaco Kraan, Wilfred F J Van IJcken, Joost Gribnau, Pakriti Garkhail, Gatske Nieuwenhuyzen-de Boer, Eva-Maria Roes, Heleen van Beekhuizen, Tuba Gunel, Saskia M Wilting, John W M Martens, Maurice Jansen, Ingrid A Boere
Epigenetic and Genomic Hallmarks of PARP-Inhibitor Resistance in Ovarian Cancer Patients. Genes 15 (6) (2024)
Tugce Senturk Kirmizitas, Caroline van den Berg, Ruben G Boers, Jean Helmijr, Stavros Makrodimitris, Hamit Harun Dag, Marijn Kerkhofs, Corine Beaufort, Jaco Kraan, Wilfred F J Van IJcken, Joost Gribnau, Pakriti Garkhail, Gatske Nieuwenhuyzen-de Boer, Eva-Maria Roes, Heleen van Beekhuizen, Tuba Gunel, Saskia M Wilting, John W M Martens, Maurice Jansen, Ingrid A Boere
Epigenetic and Genomic Hallmarks of PARP-Inhibitor Resistance in Ovarian Cancer Patients. Genes 15 (6) (2024)
Tugce Senturk Kirmizitas, Caroline van den Berg, Ruben G Boers, Jean Helmijr, Stavros Makrodimitris, Hamit Harun Dag, Marijn Kerkhofs, Corine Beaufort, Jaco Kraan, Wilfred F J Van IJcken, Joost Gribnau, Pakriti Garkhail, Gatske Nieuwenhuyzen-de Boer, Eva-Maria Roes, Heleen van Beekhuizen, Tuba Gunel, Saskia M Wilting, John W M Martens, Maurice Jansen, Ingrid A Boere
Epigenetic and Genomic Hallmarks of PARP-Inhibitor Resistance in Ovarian Cancer Patients. Genes 15 (6) (2024)
Nick J van de Berg, Gatske Nieuwenhuyzen-de Boer, Xu Shan Gao, L Lucia Rijstenberg, Heleen van Beekhuizen
Plasma Device Functions and Tissue Effects in the Female Pelvis-A Systematic Review. Cancers 15 (8) (2023)
Nick J van de Berg, Gatske Nieuwenhuyzen-de Boer, Xu Shan Gao, L Lucia Rijstenberg, Heleen van Beekhuizen
Plasma Device Functions and Tissue Effects in the Female Pelvis-A Systematic Review. Cancers 15 (8) (2023)
Gatske Nieuwenhuyzen-de Boer, Hanane Aamran, Caroline B van den Berg, Sten Willemsen, Jurgen M J Piek, Nathalie Reesink-Peters, Marianne Maliepaard, H Lena C van Doorn, Suzanne Polinder, Heleen van Beekhuizen
Cytoreductive Surgery with the PlasmaJet Improved Quality-of-Life for Advanced Stage Ovarian Cancer Patients. Cancers 15 (15) (2023)
Gatske Nieuwenhuyzen-de Boer, Malika Kengsakul, Ingrid A Boere, H Lena C van Doorn, Heleen van Beekhuizen
Unresectable Ovarian Cancer Requires a Structured Plan of Action: A Prospective Cohort Study. Cancers 15 (1) (2022)
Gatske Nieuwenhuyzen-de Boer, Malika Kengsakul, Ingrid A Boere, H Lena C van Doorn, Heleen van Beekhuizen
Unresectable Ovarian Cancer Requires a Structured Plan of Action: A Prospective Cohort Study. Cancers 15 (1) (2022)
Gatske Nieuwenhuyzen-de Boer, Malika Kengsakul, Ingrid A Boere, H Lena C van Doorn, Heleen van Beekhuizen
Unresectable Ovarian Cancer Requires a Structured Plan of Action: A Prospective Cohort Study. Cancers 15 (1) (2022)
Gatske Nieuwenhuyzen-de Boer, Alexandra J L M Geraerds, Marieke H van der Linden, Helena C van Doorn, Suzanne Polinder, Heleen van Beekhuizen
Cost Study of the PlasmaJet Surgical Device Versus Conventional Cytoreductive Surgery in Patients With Advanced-Stage Ovarian Cancer. JCO clinical cancer informatics 6 (2022)
Puck E Brons, Gatske Nieuwenhuyzen-de Boer, Christian Ramakers, Sten Willemsen, Malika Kengsakul, Heleen van Beekhuizen
Preoperative Cancer Antigen 125 Level as Predictor for Complete Cytoreduction in Ovarian Cancer: A Prospective Cohort Study and Systematic Review. Cancers 14 (23) (2022)
Puck E Brons, Gatske Nieuwenhuyzen-de Boer, Christian Ramakers, Sten Willemsen, Malika Kengsakul, Heleen van Beekhuizen
Preoperative Cancer Antigen 125 Level as Predictor for Complete Cytoreduction in Ovarian Cancer: A Prospective Cohort Study and Systematic Review. Cancers 14 (23) (2022)
Malika Kengsakul, Gatske Nieuwenhuyzen-de Boer, Suwasin Udomkarnjananun, Stephen J Kerr, Christa D Niehot, Heleen van Beekhuizen
Factors predicting postoperative morbidity after cytoreductive surgery for ovarian cancer: a systematic review and meta-analysis. Journal of gynecologic oncology 33 (4) (2022)
Puck E Brons, Gatske Nieuwenhuyzen-de Boer, Christian Ramakers, Sten Willemsen, Malika Kengsakul, Heleen van Beekhuizen
Preoperative Cancer Antigen 125 Level as Predictor for Complete Cytoreduction in Ovarian Cancer: A Prospective Cohort Study and Systematic Review. Cancers 14 (23) (2022)
Puck E Brons, Gatske Nieuwenhuyzen-de Boer, Christian Ramakers, Sten Willemsen, Malika Kengsakul, Heleen van Beekhuizen
Preoperative Cancer Antigen 125 Level as Predictor for Complete Cytoreduction in Ovarian Cancer: A Prospective Cohort Study and Systematic Review. Cancers 14 (23) (2022)
Malika Kengsakul, Gatske Nieuwenhuyzen-de Boer, Suwasin Udomkarnjananun, Stephen J Kerr, H Lena C van Doorn, Heleen van Beekhuizen
Factors Predicting 30-Day Grade IIIa-V Clavien-Dindo Classification Complications and Delayed Chemotherapy Initiation after Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: A Prospective Cohort Study. Cancers 14 (17) (2022)
Sharline M van Vliet-Pérez, Nick J van de Berg, Francesca Manni, Marco Lai, Lucia Rijstenberg, Benno H W Hendriks, Jenny Dankelman, Patricia C Ewing-Graham, Gatske Nieuwenhuyzen-de Boer, Heleen van Beekhuizen
Hyperspectral Imaging for Tissue Classification after Advanced Stage Ovarian Cancer Surgery-A Pilot Study. Cancers 14 (6) (2022)
Gatske Nieuwenhuyzen-de Boer, Jacoba van der Kooy, Heleen J van Beekhuizen
Effectiveness and safety of the PlasmaJet® Device in advanced stage ovarian carcinoma: a systematic review. Journal of ovarian research 12 (1) (2019)
Gatske Nieuwenhuyzen-de Boer, W Hofhuis, N Reesink-Peters, P C Ewing-Graham, I G Schoots, J J Beltman, J M J Piek, A Baalbergen, G S Kooi, A van Haaften, H van Huisseling, L Haans, M Dorman, H J van Beekhuizen
Evaluation of effectiveness of the PlasmaJet surgical device in the treatment of advanced stage ovarian cancer (PlaComOv-study): study protocol of a randomized controlled trial in the Netherlands. BMC cancer 19 (1) (2019)